1. Home
  2. BAX vs MEDP Comparison

BAX vs MEDP Comparison

Compare BAX & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baxter International Inc.

BAX

Baxter International Inc.

HOLD

Current Price

$18.60

Market Cap

9.4B

Sector

Health Care

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$543.83

Market Cap

13.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAX
MEDP
Founded
1931
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4B
13.4B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
BAX
MEDP
Price
$18.60
$543.83
Analyst Decision
Hold
Hold
Analyst Count
10
12
Target Price
$25.67
$465.18
AVG Volume (30 Days)
8.3M
277.0K
Earning Date
10-30-2025
10-22-2025
Dividend Yield
0.22%
N/A
EPS Growth
N/A
25.36
EPS
N/A
14.32
Revenue
$11,023,000,000.00
$2,358,373,000.00
Revenue This Year
$5.20
$21.48
Revenue Next Year
$2.02
$11.90
P/E Ratio
N/A
$38.28
Revenue Growth
3.90
13.88
52 Week Low
$17.40
$250.05
52 Week High
$37.74
$626.26

Technical Indicators

Market Signals
Indicator
BAX
MEDP
Relative Strength Index (RSI) 43.20 36.48
Support Level $18.33 $530.96
Resistance Level $19.17 $626.26
Average True Range (ATR) 0.54 18.24
MACD 0.21 -8.14
Stochastic Oscillator 63.23 17.60

Price Performance

Historical Comparison
BAX
MEDP

About BAX Baxter International Inc.

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: